Bioactive Scaffold Fabricated by 3D Printing for Enhancing Osteoporotic Bone Regeneration
We develop a poly (lactic-co-glycolic acid)/β-calcium phosphate (PLGA/TCP)-based scaffold through a three-dimensional (3D) printing technique incorporating icaritin (ICT), a unique phytomolecule, and secretome derived from human fetal mesenchymal stem cells (HFS), to provide mechanical support and biological cues for stimulating bone defect healing. With the sustained release of ICT and HFS from the composite scaffold, the cell-free scaffold efficiently facilitates the migration of MSCs and promotes bone regeneration at the femoral defect site in the ovariectomy (OVX)-induced osteoporotic rat model. Furthermore, mechanism study results indicate that the combination of ICT and HFS additively activates the Integrin-FAK (focal adhesion kinase)-ERK1/2 (extracellular signal-regulated kinase 1/2)-Runx2 (Runt-related transcription factor 2) axis, which could be linked to the beneficial recruitment of MSCs to the implant and subsequent osteogenesis enhancement. Collectively, the PLGA/TCP/ICT/HFS (P/T/I/S) bioactive scaffold is a promising biomaterial for repairing osteoporotic bone defects, which may have immense implications for their translation to clinical practice.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
Bioengineering (Basel, Switzerland) - 9(2022), 10 vom: 05. Okt. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Xiaoting [VerfasserIn] |
---|
Links: |
---|
Themen: |
Additive effect |
---|
Anmerkungen: |
Date Revised 30.10.2022 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/bioengineering9100525 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM348049013 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM348049013 | ||
003 | DE-627 | ||
005 | 20231226035257.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/bioengineering9100525 |2 doi | |
028 | 5 | 2 | |a pubmed24n1160.xml |
035 | |a (DE-627)NLM348049013 | ||
035 | |a (NLM)36290493 | ||
035 | |a (PII)525 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhang, Xiaoting |e verfasserin |4 aut | |
245 | 1 | 0 | |a Bioactive Scaffold Fabricated by 3D Printing for Enhancing Osteoporotic Bone Regeneration |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 30.10.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a We develop a poly (lactic-co-glycolic acid)/β-calcium phosphate (PLGA/TCP)-based scaffold through a three-dimensional (3D) printing technique incorporating icaritin (ICT), a unique phytomolecule, and secretome derived from human fetal mesenchymal stem cells (HFS), to provide mechanical support and biological cues for stimulating bone defect healing. With the sustained release of ICT and HFS from the composite scaffold, the cell-free scaffold efficiently facilitates the migration of MSCs and promotes bone regeneration at the femoral defect site in the ovariectomy (OVX)-induced osteoporotic rat model. Furthermore, mechanism study results indicate that the combination of ICT and HFS additively activates the Integrin-FAK (focal adhesion kinase)-ERK1/2 (extracellular signal-regulated kinase 1/2)-Runx2 (Runt-related transcription factor 2) axis, which could be linked to the beneficial recruitment of MSCs to the implant and subsequent osteogenesis enhancement. Collectively, the PLGA/TCP/ICT/HFS (P/T/I/S) bioactive scaffold is a promising biomaterial for repairing osteoporotic bone defects, which may have immense implications for their translation to clinical practice | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a PLGA/TCP | |
650 | 4 | |a additive effect | |
650 | 4 | |a focal adhesion signalling | |
650 | 4 | |a icaritin | |
650 | 4 | |a osteoporotic bone regeneration | |
650 | 4 | |a secretome | |
700 | 1 | |a Wang, Xinluan |e verfasserin |4 aut | |
700 | 1 | |a Lee, Yuk-Wai |e verfasserin |4 aut | |
700 | 1 | |a Feng, Lu |e verfasserin |4 aut | |
700 | 1 | |a Wang, Bin |e verfasserin |4 aut | |
700 | 1 | |a Pan, Qi |e verfasserin |4 aut | |
700 | 1 | |a Meng, Xiangbo |e verfasserin |4 aut | |
700 | 1 | |a Cao, Huijuan |e verfasserin |4 aut | |
700 | 1 | |a Li, Linlong |e verfasserin |4 aut | |
700 | 1 | |a Wang, Haixing |e verfasserin |4 aut | |
700 | 1 | |a Bai, Shanshan |e verfasserin |4 aut | |
700 | 1 | |a Kong, Lingchi |e verfasserin |4 aut | |
700 | 1 | |a Chow, Dick Ho Kiu |e verfasserin |4 aut | |
700 | 1 | |a Qin, Ling |e verfasserin |4 aut | |
700 | 1 | |a Cui, Liao |e verfasserin |4 aut | |
700 | 1 | |a Lin, Sien |e verfasserin |4 aut | |
700 | 1 | |a Li, Gang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Bioengineering (Basel, Switzerland) |d 2014 |g 9(2022), 10 vom: 05. Okt. |w (DE-627)NLM259987786 |x 2306-5354 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2022 |g number:10 |g day:05 |g month:10 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/bioengineering9100525 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2022 |e 10 |b 05 |c 10 |